Agilent Research Development vs Total Revenue Analysis

A Stock

USD 135.54 0.29 0.21%

Agilent Technologies financial indicator trend analysis is way more than just evaluating Agilent Technologies prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Agilent Technologies is a good investment. Please check the relationship between Agilent Technologies Research Development and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agilent Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Agilent Stock refer to our How to Trade Agilent Stock guide.

Research Development vs Total Revenue

Research Development vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Agilent Technologies Research Development account and Total Revenue. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Agilent Technologies' Research Development and Total Revenue is 0.81. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Agilent Technologies, assuming nothing else is changed. The correlation between historical values of Agilent Technologies' Research Development and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Agilent Technologies are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Research Development i.e., Agilent Technologies' Research Development and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.81

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Research Development

Total Revenue

Total revenue comprises all receipts Agilent Technologies generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Agilent Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Agilent Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agilent Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Agilent Stock refer to our How to Trade Agilent Stock guide.At present, Agilent Technologies' Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.33, whereas Selling General Administrative is forecasted to decline to about 1.4 B.

	2021	2022	2023	2024 (projected)
Interest Expense	84M	95M	96M	91.2M
Depreciation And Amortization	317M	271M	243.9M	259.0M

Interest Expense Depreciation And Amortization

Agilent Technologies fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Current Deferred Revenue	Common Stock Total Equity	Common Stock	Short Long Term Debt Total	Other Liab	Net Debt	Retained Earnings	Cash	Other Assets
Total Assets		0.14	0.54	0.97	0.25	0.56	0.93	0.54	0.4	-0.73	0.95	0.03	0.1	0.04	0.99	0.45	0.54	0.91	-0.14	-0.14	0.97	0.34	0.64	0.03	0.11	0.46
Other Current Liab	0.14		0.48	0.06	0.94	0.47	0.11	0.61	0.46	0.13	-0.04	0.53	0.55	0.36	0.19	0.74	-0.17	0.35	-0.21	-0.22	0.07	-0.2	0.53	-0.24	-0.45	0.37
Total Current Liabilities	0.54	0.48		0.46	0.43	0.77	0.61	0.52	0.71	-0.06	0.33	0.55	0.36	0.31	0.59	0.41	0.12	0.62	-0.31	-0.3	0.42	0.11	0.49	-0.24	-0.37	0.59
Total Stockholder Equity	0.97	0.06	0.46		0.21	0.5	0.91	0.47	0.4	-0.77	0.92	-0.02	0.02	0.11	0.92	0.47	0.53	0.9	-0.22	-0.22	0.96	0.19	0.61	-0.04	0.12	0.39
Property Plant And Equipment Net	0.25	0.94	0.43	0.21		0.51	0.17	0.64	0.52	0.04	0.07	0.58	0.59	0.35	0.26	0.84	-0.02	0.49	-0.2	-0.21	0.17	-0.25	0.55	-0.21	-0.37	0.3
Accounts Payable	0.56	0.47	0.77	0.5	0.51		0.55	0.7	0.86	-0.04	0.42	0.73	0.59	0.18	0.58	0.56	0.33	0.75	-0.2	-0.19	0.43	-0.04	0.43	-0.1	-0.3	0.44
Non Current Assets Total	0.93	0.11	0.61	0.91	0.17	0.55		0.57	0.52	-0.76	0.86	-0.03	-0.08	0.24	0.91	0.45	0.24	0.88	-0.37	-0.37	0.92	0.22	0.74	-0.2	-0.18	0.56
Non Currrent Assets Other	0.54	0.61	0.52	0.47	0.64	0.7	0.57		0.69	-0.23	0.46	0.45	0.48	0.27	0.57	0.64	0.06	0.72	-0.25	-0.25	0.47	-0.03	0.67	-0.17	-0.44	0.47
Net Receivables	0.4	0.46	0.71	0.4	0.52	0.86	0.52	0.69		-0.06	0.22	0.7	0.37	0.51	0.39	0.65	-0.03	0.69	-0.52	-0.51	0.3	-0.34	0.54	-0.43	-0.63	0.57
Common Stock Shares Outstanding	-0.73	0.13	-0.06	-0.77	0.04	-0.04	-0.76	-0.23	-0.06		-0.74	0.55	0.45	-0.22	-0.68	-0.34	-0.1	-0.55	0.35	0.35	-0.84	-0.15	-0.68	0.21	0.0	-0.32
Non Current Liabilities Total	0.95	-0.04	0.33	0.92	0.07	0.42	0.86	0.46	0.22	-0.74		-0.12	0.03	-0.16	0.95	0.27	0.6	0.81	0.02	0.03	0.95	0.46	0.5	0.2	0.27	0.32
Inventory	0.03	0.53	0.55	-0.02	0.58	0.73	-0.03	0.45	0.7	0.55	-0.12		0.79	0.06	0.06	0.38	0.22	0.33	0.04	0.04	-0.15	-0.23	0.01	0.04	-0.26	0.21
Other Current Assets	0.1	0.55	0.36	0.02	0.59	0.59	-0.08	0.48	0.37	0.45	0.03	0.79		-0.32	0.14	0.31	0.43	0.31	0.43	0.43	-0.03	-0.09	-0.03	0.43	0.02	-0.06
Other Stockholder Equity	0.04	0.36	0.31	0.11	0.35	0.18	0.24	0.27	0.51	-0.22	-0.16	0.06	-0.32		-0.01	0.51	-0.56	0.18	-0.97	-0.97	0.03	-0.36	0.51	-0.99	-0.67	0.43
Total Liab	0.99	0.19	0.59	0.92	0.26	0.58	0.91	0.57	0.39	-0.68	0.95	0.06	0.14	-0.01		0.42	0.53	0.89	-0.08	-0.08	0.95	0.43	0.64	0.08	0.1	0.5
Property Plant And Equipment Gross	0.45	0.74	0.41	0.47	0.84	0.56	0.45	0.64	0.65	-0.34	0.27	0.38	0.31	0.51	0.42		-0.1	0.65	-0.43	-0.44	0.42	-0.34	0.8	-0.38	-0.52	0.55
Total Current Assets	0.54	-0.17	0.12	0.53	-0.02	0.33	0.24	0.06	-0.03	-0.1	0.6	0.22	0.43	-0.56	0.53	-0.1		0.44	0.5	0.5	0.46	0.37	-0.23	0.61	0.77	-0.17
Current Deferred Revenue	0.91	0.35	0.62	0.9	0.49	0.75	0.88	0.72	0.69	-0.55	0.81	0.33	0.31	0.18	0.89	0.65	0.44		-0.26	-0.26	0.85	0.06	0.68	-0.09	-0.13	0.46
Common Stock Total Equity	-0.14	-0.21	-0.31	-0.22	-0.2	-0.2	-0.37	-0.25	-0.52	0.35	0.02	0.04	0.43	-0.97	-0.08	-0.43	0.5	-0.26		1.0	-0.15	0.35	-0.51	0.97	0.62	-0.39
Common Stock	-0.14	-0.22	-0.3	-0.22	-0.21	-0.19	-0.37	-0.25	-0.51	0.35	0.03	0.04	0.43	-0.97	-0.08	-0.44	0.5	-0.26	1.0		-0.15	0.35	-0.52	0.97	0.63	-0.4
Short Long Term Debt Total	0.97	0.07	0.42	0.96	0.17	0.43	0.92	0.47	0.3	-0.84	0.95	-0.15	-0.03	0.03	0.95	0.42	0.46	0.85	-0.15	-0.15		0.26	0.66	0.03	0.12	0.42
Other Liab	0.34	-0.2	0.11	0.19	-0.25	-0.04	0.22	-0.03	-0.34	-0.15	0.46	-0.23	-0.09	-0.36	0.43	-0.34	0.37	0.06	0.35	0.35	0.26		-0.07	0.33	0.44	0.12
Net Debt	0.64	0.53	0.49	0.61	0.55	0.43	0.74	0.67	0.54	-0.68	0.5	0.01	-0.03	0.51	0.64	0.8	-0.23	0.68	-0.51	-0.52	0.66	-0.07		-0.43	-0.58	0.7
Retained Earnings	0.03	-0.24	-0.24	-0.04	-0.21	-0.1	-0.2	-0.17	-0.43	0.21	0.2	0.04	0.43	-0.99	0.08	-0.38	0.61	-0.09	0.97	0.97	0.03	0.33	-0.43		0.65	-0.36
Cash	0.11	-0.45	-0.37	0.12	-0.37	-0.3	-0.18	-0.44	-0.63	0.0	0.27	-0.26	0.02	-0.67	0.1	-0.52	0.77	-0.13	0.62	0.63	0.12	0.44	-0.58	0.65		-0.5
Other Assets	0.46	0.37	0.59	0.39	0.3	0.44	0.56	0.47	0.57	-0.32	0.32	0.21	-0.06	0.43	0.5	0.55	-0.17	0.46	-0.39	-0.4	0.42	0.12	0.7	-0.36	-0.5

Click cells to compare fundamentals

Agilent Technologies Account Relationship Matchups

Agilent Technologies fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	9.6B	10.7B	10.5B	10.8B	11.8B	9.4B
Other Current Liab	601M	769M	733M	634M	1.3B	1.4B
Total Current Liabilities	1.5B	1.7B	1.9B	1.6B	1.9B	1.4B
Total Stockholder Equity	4.9B	5.4B	5.3B	5.8B	5.9B	4.8B
Property Plant And Equipment Net	845M	945M	1.1B	1.3B	1.8B	1.9B
Non Current Assets Total	6.2B	6.9B	6.8B	6.6B	7.9B	4.8B
Non Currrent Assets Other	776M	511M	686M	424M	910M	587.5M
Net Receivables	1.0B	1.2B	1.4B	1.3B	1.3B	807.3M
Common Stock Shares Outstanding	312M	307M	300M	296M	291M	302.4M
Liabilities And Stockholders Equity	9.6B	10.7B	10.5B	10.8B	11.8B	9.4B
Non Current Liabilities Total	3.3B	3.6B	3.4B	3.3B	4.1B	2.7B
Inventory	720M	830M	1.0B	1.0B	972M	742.1M
Other Current Assets	216M	222M	282M	274M	334M	283.2M
Other Stockholder Equity	5.3B	5.3B	5.3B	5.4B	5.5B	5.7B
Total Liab	4.8B	5.3B	5.2B	4.9B	5.9B	4.6B
Property Plant And Equipment Gross	845M	2.1B	2.2B	2.5B	2.9B	3.0B
Total Current Assets	3.4B	3.8B	3.8B	4.2B	4.0B	3.4B
Accumulated Other Comprehensive Income	(522M)	(282M)	(347M)	(327M)	(305M)	(320.3M)
Current Deferred Revenue	386M	441M	461M	505M	580.8M	364.3M
Short Long Term Debt Total	2.4B	2.4B	2.8B	2.8B	3.4B	2.4B
Other Liab	876M	879M	633M	462M	531.3M	776.8M
Net Debt	918M	1.2B	1.7B	1.1B	2.1B	2.2B
Retained Earnings	81M	348M	324M	782M	750M	712.5M
Cash	1.4B	1.5B	1.1B	1.6B	1.3B	1.6B
Other Assets	601M	820M	670M	554M	498.6M	642.3M
Cash And Short Term Investments	1.4B	1.6B	1.1B	1.6B	1.3B	1.6B
Good Will	3.6B	5.0B	4.0B	4.0B	4.5B	2.4B
Short Term Debt	126M	52M	87M	46M	45M	42.8M
Intangible Assets	831M	981M	821M	475M	547M	650.8M
Property Plant Equipment	845M	945M	1.1B	1.4B	1.3B	845.4M
Long Term Debt	2.3B	2.7B	2.7B	2.7B	3.1B	2.3B
Long Term Debt Total	2.3B	2.7B	2.7B	2.7B	3.1B	2.3B
Net Tangible Assets	440M	433M	516M	1.4B	1.3B	953.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

How To Invest In Agilent

Details

Is Agilent Stock a good investment?

Details

What is Agilent Technologies' Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agilent Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For information on how to trade Agilent Stock refer to our How to Trade Agilent Stock guide.

You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilent Technologies. If investors know Agilent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilent Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.569

Earnings Share

4.43

Revenue Per Share

22.269

Quarterly Revenue Growth

(0.06)

Return On Assets

0.0758

The market value of Agilent Technologies is measured differently than its book value, which is the value of Agilent that is recorded on the company's balance sheet. Investors also form their own opinion of Agilent Technologies' value that differs from its market value or its book value, called intrinsic value, which is Agilent Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilent Technologies' market value can be influenced by many factors that don't directly affect Agilent Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Agilent Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agilent Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilent Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Agilent Research Development vs Total Revenue Analysis

Research Development vs Total Revenue

Research Development vs Total Revenue Correlation Analysis

Correlation Coefficient

Research Development

Total Revenue

Agilent Technologies fundamental ratios Correlations

Agilent Technologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Agilent Technologies fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock	+ 1.0	Common Stock Total Equity
Total Liab	+ 0.99	Total Assets
Total Stockholder Equity	+ 0.97	Total Assets
Short Long Term Debt Total	+ 0.97	Total Assets
Retained Earnings	+ 0.97	Common Stock Total Equity
Retained Earnings	+ 0.97	Common Stock

Retained Earnings	- 0.99	Other Stockholder Equity
Common Stock	- 0.97	Other Stockholder Equity
Common Stock Total Equity	- 0.97	Other Stockholder Equity
Short Long Term Debt Total	- 0.84	Common Stock Shares Outstanding
Common Stock Shares Outstanding	- 0.77	Total Stockholder Equity
Common Stock Shares Outstanding	- 0.76	Non Current Assets Total